Allogeneic and autologous serum eye drops: a pilot double‐blind randomized crossover trial

Abstract

Autologous and allogeneic SEDs have comparable efficacy and tolerability for use in patients with severe dry eyes. Allogeneic SEDs are therefore an attractive alternative for patients who need SEDs but are clinically or logistically unable to donate blood.